Opus Genetics is developing a gene therapy to treat ultra-rare retinal degenerative diseases.
Company Location
223 South West St., Suite 900
Raleigh
NC
27603
County
Region
Company Details
Company type
Year founded
2021
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
Opus’ lead programs focus on treatments delivered subretinally to address mutations in genes that cause different forms of Leber congenital amaurosis (LCA): OPGx-001, OPGx-002, OPGx-003